| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Jeffrey B Anderson, MD |
Use of Oxandrolone to Promote Growth in Infants with Hypoplastic Left Heart Syndrome: A Phase I/II Pilot Study ("Ox") |
New England Research Institutes (National Institutes of Health (NIH)) |
Ox |
11/14/2017 - 11/13/2021 |
$15,825 |
| Andrea Z Beaton, MD |
Determining the impact of penicillin on latent Rheumatic Heart Disease |
Thrasher Research Fund |
Beaton, Andrea, TRF |
12/1/2018 - 11/30/2019 |
$143,932 |
| Andrea Z Beaton, MD |
Strengthening the Health System Response to Rheumatic Heart Disease: Developing Evidence-Based Strategies for Prevention |
Children's National Medical Center (American Heart Association - National) |
3000410508 |
9/17/2018 - 6/30/2019 |
$57,982 |
| James F Cnota, MD |
Pediatric Heart Network Prairieland Consortium |
National Institutes of Health (NIH) |
UG1HL135678 |
1/1/2018 - 12/31/2019 |
$350,064 |
| James F Cnota, MD |
Single Institutional Review Board (SIRB): PHN Subcontract |
New England Research Institutes (National Institutes of Health (NIH)) |
NERI, Cnota, James |
2/2/2018 - 6/30/2019 |
$133,287 |
| Bryan H Goldstein, MD |
PHN Scholar Award |
Children's Hospital of Philadelphia (New England Research Institutes) |
8903910620 |
7/1/2018 - 6/30/2020 |
$19,350 |
| Garick D Hill, MD-MS |
Risk adjusted evaluation of Fontan Fenestration |
New England Research Institutes (National Institutes of Health (NIH)) |
Hill PHN Award |
2/2/2018 - 6/30/2020 |
$75,000 |
| Russel Hirsch, MD |
Pulmonary vein stenosis: disease mechanisms and outcomes |
The Hospital for Sick Children |
Hirsch, Russel, HSC |
12/13/2018 - 12/13/2023 |
$16,875 |
| Shelley Kirk, PHD |
Enhancing effectiveness of existing weight management programs for teens with severe obesity: A 6-month feasibility pilot study |
National Institutes of Health (NIH) |
R34DK118510 |
1/1/2018 - 7/31/2019 |
$249,211 |
| Adam M Lubert, MD |
Adult Congenital Heart Disease Patient-Reported Outcome (ACHD PRO) Tool |
The University of Texas Southwestern |
GMO191211 |
12/3/2018 - 12/31/2019 |
$10,000 |
| Elaine Urbina, MD |
Pediatric HIV/AIDS Cohort Study (PHACS 3) |
Tulane University (National Institutes of Health (NIH)) |
TUL-HSC-555755-17 |
2/2/2018 - 7/31/2019 |
$21,828 |
| Elaine Urbina, MD |
TODAY2 Phase 2 (T2P2): Long-Term Post-Intervention Follow-Up |
George Washington University (National Institutes of Health (NIH)) |
14-D05 |
2/2/2018 - 4/30/2019 |
$49,556 |
| Elaine Urbina, MD |
HDL composition/function and cardiovascular risk in youths with diabetes |
University of Washington (National Institutes of Health (NIH)) |
UWSC10977 |
2/2/2018 - 11/30/2019 |
$39,849 |
Jessica Woo, PHD
Elaine M Urbina, MD |
Childhood CV Risk and Adult CVD Outcomes: an Internation |
National Institutes of Health (NIH) |
R01HL121230 |
1/1/2018 11/30/2019 |
$1,302,164 |
| Current Year Direct |
$2,484,923 |
